Tuberculosis Study
- All
- News
- Videos
-
6-Month Drug-Resistant Tuberculosis Treatment More Effective, Cheaper Than Existing Regimens: ICMR Study
The ICMR analysis found that the BPaL regimen is "both more effective and cost-saving" compared to the current standard of care.
-
Tuberculosis: Short 6-Month Oral Treatment Plan Proves Affordable In India
Shorter, six month and alloral treatment regimens for multidrugresistant and rifampicinresistant tuberculosis (MDR/RRTB) are costeffective and deliver better health outcomes than longer regimens.
-
AI-Enabled Stethoscopes Show Promise In Improving Health Screenings
As tuberculosis (TB) continues as the deadliest infectious cause of deaths globally, a new study has shown that artificial intelligence (AI)-enabled digital stethoscopes can help fill critical screening gaps, especially in hard-to-reach areas.
-
Tuberculosis Bacteria Are Mutating, Turning Antibiotic Resistant: IIT Bombay Study
The bacteria Mycobacterium tuberculosis, which causes the world's most infectious disease Tuberculosis (TB), can survive antibiotic treatment and live longer by changing their outer fat coating, according to a new study.
-
Study By Indian Doctor Couple Inspires Major WHO Change In Tuberculosis Treatment And Care
The World Health Organization (WHO) has released revised guidelines on tuberculosis (TB) and undernutrition, introducing a novel recommendation rooted in evidence from India's landmark RATIONS trial.
-
Higher Dose of This Antibiotic Can Help In Tuberculosis Recovery: Study
A higher dose of rifampicin -- a bactericidal antibiotic used primarily to treat tuberculosis (TB) -- may be safe, and its use can potentially lead to recurrence-free survival in patients with pulmonary TB, according to a recent study by ICMR.
-
Local Weather Conditions Can Impact Prevalence Of Tuberculosis: Study
Researchers who mapped tuberculosis cases in African countries found that local weather conditions and access to cities can influence prevalence of the bacterial disease.
-
Brazil, Russia, India and South Africa To Study Intersection Of Covid, Tuberculosis Pandemics
A consortium of doctors and researchers from India, Brazil, Russia, and South Africa have partnered to conduct a study on the epidemiological impact and intersection of the COVID-19 and Tuberculosis pandemics in these countries, Ministry of Science a
-
Top Medical Body To Evaluate If BCG Vaccine Effective To Prevent COVID-19 In Elderly People
Top medical body ICMR is undertaking a study in Mumbai to evaluate whether the BCG (Bacille Calmette-Guerin) vaccine, primarily used against tuberculosis, is effective in preventing COVID-19 in elderly population, the city civic body said on Friday.
-
Tamil Nadu Nod To Study BCG Vaccine Efficacy In Elderly In COVID Fight
Sanction has been accorded to a trial by the Indian Council of Medical Research's tuberculosis institute in Chennai to study the efficacy of BCG vaccine in the elderly in the fight against COVID-19, the government said on Wednesday.
-
6-Month Drug-Resistant Tuberculosis Treatment More Effective, Cheaper Than Existing Regimens: ICMR Study
The ICMR analysis found that the BPaL regimen is "both more effective and cost-saving" compared to the current standard of care.
-
Tuberculosis: Short 6-Month Oral Treatment Plan Proves Affordable In India
Shorter, six month and alloral treatment regimens for multidrugresistant and rifampicinresistant tuberculosis (MDR/RRTB) are costeffective and deliver better health outcomes than longer regimens.
-
AI-Enabled Stethoscopes Show Promise In Improving Health Screenings
As tuberculosis (TB) continues as the deadliest infectious cause of deaths globally, a new study has shown that artificial intelligence (AI)-enabled digital stethoscopes can help fill critical screening gaps, especially in hard-to-reach areas.
-
Tuberculosis Bacteria Are Mutating, Turning Antibiotic Resistant: IIT Bombay Study
The bacteria Mycobacterium tuberculosis, which causes the world's most infectious disease Tuberculosis (TB), can survive antibiotic treatment and live longer by changing their outer fat coating, according to a new study.
-
Study By Indian Doctor Couple Inspires Major WHO Change In Tuberculosis Treatment And Care
The World Health Organization (WHO) has released revised guidelines on tuberculosis (TB) and undernutrition, introducing a novel recommendation rooted in evidence from India's landmark RATIONS trial.
-
Higher Dose of This Antibiotic Can Help In Tuberculosis Recovery: Study
A higher dose of rifampicin -- a bactericidal antibiotic used primarily to treat tuberculosis (TB) -- may be safe, and its use can potentially lead to recurrence-free survival in patients with pulmonary TB, according to a recent study by ICMR.
-
Local Weather Conditions Can Impact Prevalence Of Tuberculosis: Study
Researchers who mapped tuberculosis cases in African countries found that local weather conditions and access to cities can influence prevalence of the bacterial disease.
-
Brazil, Russia, India and South Africa To Study Intersection Of Covid, Tuberculosis Pandemics
A consortium of doctors and researchers from India, Brazil, Russia, and South Africa have partnered to conduct a study on the epidemiological impact and intersection of the COVID-19 and Tuberculosis pandemics in these countries, Ministry of Science a
-
Top Medical Body To Evaluate If BCG Vaccine Effective To Prevent COVID-19 In Elderly People
Top medical body ICMR is undertaking a study in Mumbai to evaluate whether the BCG (Bacille Calmette-Guerin) vaccine, primarily used against tuberculosis, is effective in preventing COVID-19 in elderly population, the city civic body said on Friday.
-
Tamil Nadu Nod To Study BCG Vaccine Efficacy In Elderly In COVID Fight
Sanction has been accorded to a trial by the Indian Council of Medical Research's tuberculosis institute in Chennai to study the efficacy of BCG vaccine in the elderly in the fight against COVID-19, the government said on Wednesday.
